StarZero All shows Try the podcast clipper →

Horizon Therapeutics

2 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement May 19, 2023 by David Friedberg · said 4 times in 1 episodes since 2023 · across every show →

Mentions by year

brought up most by Jason Calacanis (4)

tap a year for its mentions
0021412023episodesmentions
0112023episodes it came up in
0020.5412023episodesmentions per episode
2023 4 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about Horizon Therapeutics, oldest first

May 19, 2023 positive
Opinion
Friedberg: FTC's antitrust case against Amgen acquiring Horizon is compelling
“I felt like it was a fairly kind of Compelling case. I'm the lawyer on antitrust and monopolistic practices and the Sherman Act, but this was not sorry, let me just say this was not an early stage biotech risky deal that they're trying to block.”
David Friedberg May 19, 2023 ▶ 55:10 E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more
May 19, 2023 neutral
Assertion Partly supported
Friedberg: Horizon Therapeutics generates $4B annual revenue and $1B-$1.5B EBITDA
“The company that Amgen is trying to buy is called Horizon Therapeutics, which is a company that's doing about four billion in revenue a year about a billion to a billion and a half in EBITDA.”
David Friedberg May 19, 2023 ▶ 53:26 E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more